Effects of CytoReductive surgery plus hyperthermic IntraPEritoneal chemotherapy (HIPEC) versus CytoReductive surgery for ovarian cancer patients: A systematic review and meta-analysis
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Oncology,General Medicine,Surgery
Reference40 articles.
1. Cancer statistics;Siegel;CA A Cancer J Clin,2017
2. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments;Kyrgiou;J Natl Cancer Inst,2006
3. Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on relapse pattern in primary epithelial ovarian cancer: a propensity score based case-control study;Ceresoli;J Gynecol Oncol,2018
4. Peritoneal-plasma barrier;Jacquet PSugarbaker;Cancer Treat Res,1996
5. Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis;Sugarbaker;Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol,2011
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Should We Abandon Intraperitoneal Chemotherapy in the Treatment of Advanced Ovarian Cancer? A Meta-Analysis;Journal of Personalized Medicine;2023-11-23
2. Cytoreduction Plus Hyperthermic Intraperitoneal Chemotherapy in Primary and Recurrent Ovarian Cancer: A Single-Center Cohort Study;Surgeries;2023-11-22
3. Progress in the Treatment of Peritoneal Metastatic Cancer and the Application of Therapeutic Nanoagents;ACS Applied Bio Materials;2023-11-02
4. Localized chemotherapy approaches and advanced drug delivery strategies: a step forward in the treatment of peritoneal carcinomatosis from ovarian cancer;Frontiers in Oncology;2023-05-23
5. Prognostic value and adverse events of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in primary advanced and platinum-sensitive recurrent epithelial ovarian cancer: a systematic review and meta-analysis;International Journal of Hyperthermia;2023-02-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3